332: Pfizer's new R&D head, a VC deep-dive, and a new FDA commissioner?
The Readout Loud
00:00
Strategic Shifts in Meeting Formats and Personal Reflections
This chapter explores the decision to move away from the JP Morgan conference, highlighting its benefits and the resulting increased productivity in discussions with pharmaceutical companies. It also features a humorous exchange about skiing, concluding with kudos to the production team and a call for listener engagement.
Transcript
Play full episode
